Search of Protein Biomarkers in Order to Achieve a Molecular Classification of Gliomas
NCT02473484 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 78
Last updated 2017-12-22
Summary
The aim is to classify high grade glioma by matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI). In order to provide more specific informations for the diagnosis and the prognosis of high grade glioma.
Conditions
Sponsors & Collaborators
-
University Hospital, Lille
lead OTHER
Principal Investigators
-
Emilie Le RHUN, MD · University Hospital, Lille
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-06-24
- Primary Completion
- 2017-10-31
- Completion
- 2017-10-31
Countries
- France
Study Locations
More Related Trials
-
Analysis of Circulating DNA in Blood Samples of Glioma-affected Patients
NCT05964153 ·Status: UNKNOWN ·Phase: NA
-
Mapping Molecular Markers of Brain Tumour Activity Using MRI
NCT05140785 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluation of the Correlation Between Molecular Phenotype and Radiological Signature (by PET-scanner and MRI) of Incident WHO II and III Grade Gliomas.
NCT04461002 ·Status: COMPLETED
-
New Antigens Against Glioblastoma
NCT05917821 ·Status: NOT_YET_RECRUITING
-
Personalized Translational Platform for Biomarker Discovery in Brain Tumors
NCT01240161 ·Status: COMPLETED
-
Laboratory Study of Early Tumor Markers in the Peripheral Blood of Glioblastoma Multiforme Patients
NCT01135875 ·Status: COMPLETED
-
MR Textural Analysis in Low Grade Gliomas
NCT04719806 ·Status: COMPLETED
-
Improving Surgical Outcomes in Patients With Low Grade Gliomas Using Advanced Pre- and Intra-operative MRI
NCT02884947 ·Status: COMPLETED
-
Correlative Analysis Between Magnetic Resonance Spectroscopy (MRS) and Essential Clinicobiological Data in Glioblatoma Multiforme (GBM)
NCT07211841 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Magnetic Resonance Imaging in Determining Extent of Cancer in Patients With Newly Diagnosed Glioma
NCT00005082 ·Status: COMPLETED ·Phase: NA
-
Study of the Capacity of the MRI Spectroscopy to Define the Tumor Area Enriched in Glioblastoma Stem Cells. Proof of Concept Study
NCT01872221 ·Status: COMPLETED ·Phase: NA
-
Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Evaluating Patients Who Are Undergoing Treatment for Gliomas
NCT00274755 ·Status: COMPLETED ·Phase: PHASE2
-
Differentiation of Progression From Treatment Effects in High-Grade Gliomas: A Clinical Trial With Multimodality MR Imaging
NCT03102203 ·Status: UNKNOWN
-
Fluorescence Spectroscopy Guided Surgery
NCT02473380 ·Status: COMPLETED ·Phase: PHASE1
-
Immunophenotyping From Blood of Patients With Malignant Gliomas
NCT02022384 ·Status: COMPLETED
-
AI-assisted Diagnosis of Malignant Brain Tumors
NCT07198256 ·Status: RECRUITING
-
HYPONCO - Hypoxia in Brain Tumors
NCT01200134 ·Status: COMPLETED ·Phase: PHASE2
-
Determination of Immune Phenotype in Glioblastoma Patients
NCT02751138 ·Status: COMPLETED
-
18F-PSMA PET/CT for Visualization of Glioblastoma Multiforme
NCT04588454 ·Status: UNKNOWN ·Phase: NA
-
Genetic and Molecular Characterization of Nervous System Lesions
NCT06314607 ·Status: RECRUITING
-
Molecular Imaging of Cancer-associated Fibroblasts in Glioblastoma: a FAPI PET/MR Study.
NCT07119294 ·Status: RECRUITING ·Phase: NA
-
Research of Molecular and Metabolic Markers in Oligodendrogliomas Comparatively to Other Brain Tumours
NCT00213876 ·Status: COMPLETED
-
Clinical Development of MR Spectroscopy and Imaging in Brain Cancers
NCT02731521 ·Status: COMPLETED
-
Multimodal Imaging of Hypoxia in Gliomas
NCT03716986 ·Status: UNKNOWN ·Phase: NA
-
Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain Tumors
NCT00005083 ·Status: WITHDRAWN ·Phase: PHASE2